MOORSIDE PHARMA DEVELOPMENTS LIMITED
Company number 07930921 · Active · Bradford BD2 3AA
MOORSIDE PHARMA DEVELOPMENTS LIMITED is an active private limited company (company number 07930921) incorporated on 1 February 2012, registered in Bradford. Its registered activity is dispensing chemist in specialised stores (SIC 47730). Latest micro accounts cover the period ending 28 February 2025, showing net assets of −£53k, with 7 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 836% on the prior period (−£5,614).
By net assets it sits in the bottom quarter of 326 comparable companies in Leeds (median £18k, upper quartile £165k).
Key dates
- Incorporated
- 1 February 2012
- Next accounts due
- 28 November 2026 — in 40 days
- Confirmation statement due
- 15 February 2027 — in 119 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 47730
- Dispensing chemist in specialised stores
- SIC 86900
- Other human health activities
- Accounts type
- Micro Entity
- Size band
- Micro (Companies Act thresholds)
Financials — 2 periods on record, latest ending 28 February 2025
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 28 February 2025 | −£53k | — | — | — | — | — | 7 |
| 29 February 2024 | −£5,614 | — | — | — | — | — | 7 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Firmoscan score: 35/100 (grade D)
- -15 Negative net assets — Net assets £-52,522 at 2025-02-28
- -8 Net assets falling — -835.6% vs prior period
- +8 Established — Incorporated 2012-02-01 (15 years)
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice.
Ownership and control
- Rycroft Partnership Llp (corporate entity, England) — owns 25–50% of shares; holds 25–50% of voting rights · since 6 April 2016
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Similar companies in Leeds
Same activity (dispensing chemist in specialised stores), closest in incorporation date.
- HG HEALTHCARE LIMITED — Wakefield, inc. Feb 2012
- RED OAK HEALTHCARE LIMITED — Bradford, inc. Jan 2012
- CERTUS HEALTHCARE LIMITED — Bradford, inc. Jan 2012
- MEDPHARM VENTURES LTD — Shipley, inc. Jan 2012
- MEDWEST LIMITED — Bradford, inc. Feb 2012
- PHARM-X LTD — Bradford, inc. Mar 2012
Reminders for MOORSIDE PHARMA DEVELOPMENTS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.